Search

Search Constraints

You searched for: Author/Creator Uoshima, Nobuhiko

Search Results

1. Chromosomal abnormality variation detected by G‐banding is associated with prognosis of diffuse large B‐cell lymphoma treated by R‐CHOP‐based therapy. (23rd February 2018)

2. Clinical manifestation and prognostic factors of 32 Japanese patients with autoimmune disease-associated diffuse large B-cell lymphoma. Issue 3 (March 2015)

3. Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial. Issue 12 (December 2015)

4. Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study. (5th November 2020)

5. Epigenetic repression of miR‐375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma. (25th April 2017)

6. High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif. Issue 1 (December 2017)

7. Long‐term outcomes and central nervous system relapse in extranodal natural killer/T‐cell lymphoma. Issue 4 (2nd March 2022)

8. Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial. Issue 12 (December 2021)

9. Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide. (December 2022)

10. Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia. Issue 4 (27th January 2023)